里斯佩里用于治疗与痴呆相关的精神病:系统性审查和元分析
相关实验视频
Updated: Jun 11, 2025
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.4K
Guanghua Zhou1, Suna Yin2, Shubao Zhang1
1Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng, China.
Dementia and geriatric cognitive disorders
|September 29, 2024
概括
里斯佩里有效治疗痴呆相关精神病 (DRP),益处随时间和剂量增加而增加. 然而,它可能会恶化认知功能,由于安全问题和数据异质性,需要个性化治疗计划.
科学领域:
- 老年精神病学是一门精神病学专业.
- 临床药理学 临床药理学
- 基于证据的医学基于证据的医学.
背景情况:
- 与痴呆相关的精神病 (DRP) 在患者护理中提出了重大挑战.
- 非典型抗精神病药物Risperidone经常用于DRP,但其疗效和安全性数据是相互矛盾的.
研究的目的:
- 进行对RISPERIDONE在治疗DRP的疗效和安全性的系统审查和元分析.
- 综合现有研究,以更清楚地了解瑞斯佩里对DRP症状和认知功能的影响.
主要方法:
- 在主要数据库 (PubMed,Scopus,Web of Science,Google Scholar,PsychINFO) 进行系统的文献搜索,截至2024年5月.
- 17项涉及2311名被诊断患有DRP的患者的研究的元分析.
- 统计分析包括标准化平均差异 (SMD) 和异质性评估.
主要成果:
- 里斯佩里在缓解DRP症状方面表现出显著的影响 (SMD = 0.355,p = 0.000).
- 治疗疗效与治疗持续时间 (p = 0.038) 和剂量 (p = 0.000) 有正相关.
- 对六项研究的分析表明,RISPERIDONE的使用与DRP患者的认知功能恶化有关 (SMD = -0.185,p = 0.028).
结论:
- 这一元分析支持RISPERIDONE在治疗DRP症状方面的有效性.
- 显著的异质性和对认知的潜在不良影响需要仔细考虑和个性化治疗方法来治疗DRP中的RISPERIDONE.
- 可能需要进一步的研究,以充分阐明risperidone在这个人群中的风险-益处概况.
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
187
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
187
01:26Psychosis: Goals of Pharmacotherapy
110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:21Antipsychotic Drugs: Typical and Atypical Agents
160
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
160
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
129
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
129
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170